Mitral Valve

The heart's mitral valve is the site of the most surgical valve repairs and valve replacements. After the resounding success of transcatheter aortic valve replacement (TAVR), which now makes up more than 50% of aortic valve replacements, there is wide expectation transcatheter mitral replacements will follow in the next few year. Currently, the most common transcatheter mitral procedure is transcatheter edge-to-edge (TEER) , using the MitraClip or Pascal clip devices. These devices are also being used for transcatheter tricuspid valve repair (TTVR). Other transcatheter mitral repair systems are in trials for minimally invasive annuloplasty and chordae tendineae repair. 

RSS icon

PHOTO GALLERY: Interventional cardiology technologies at TCT 2023

Browse through some of the many highlights from TCT 2023 in San Francisco.

Video of Kendra Grubb discussing transcatheter tricuspid and mitral advancements at TCT 2023.

Key trends in transcatheter tricuspid and mitral valve technologies

The mitral valve has been an especially challenging target for transcatheter interventions, but there are reasons to think key breakthroughs are on the horizon. We talked to Kendra Grubb, MD, about this and other ongoing trends at TCT 2023. 

Akhil Narang, MD, director of the echocardiography laboratory at Northwestern Medicine explains the latest trends in structural heart interventional imaging. #ASE #ASE23 #ASE2023 #structuralheart #echofirst

The evolving roles of TEE and ICE in structural heart interventions

Akhil Narang, MD, explained that the two technologies can be used together to deliver high-quality patient care. 

A late-breaking science presentation at the annual TCT interventional cardiology meeting.

Late-breaking clinical trials at TCT 2023

Here is a list of all the late-breaking clinical trials being presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2023 annual meeting Oct. 23-26, 2023, in San Francisco.

How monitoring MR can help cardiologists anticipate TAVR outcomes in patients with low-flow, low-gradient AS

Researchers uncovered new details about how mitral regurgitation can impact one-year TAVR outcomes, sharing their findings in the Journal of the American Heart Association.

Performing valve-in-valve transcatheter mitral valve replacement (ViV TMVR) with conscious sedation (CS) or monitored anesthesia care (MAC) instead of general anesthesia (GA) is safe and effective, according to new research published in JACC: Cardiovascular Interventions.

Cardiologists detail long-term outcomes of valve-in-valve TMVR

New research published in the Canadian Journal of Cardiology represents one the most detailed pictures to date of the long-term impact of ViV TMVR.

Video of Rebecca Hahn, MD, explains the roles and economics of interventional echocardiographers. #ASE #ASE23 #Structuralheart #echofirst

Interventional echocardiographers play a key role in the treatment of structural heart disease

Rebecca Hahn, MD, examines the growing role of the dedicated interventional echocardiographer and how these imagers are paid.

Mitral valve repair: How a minimally invasive approach compares to conventional surgery

Researchers compared minithoracotomy, a minimally invasive procedure for treating degenerative mitral regurgitation, with conventional surgery, sharing their findings in JAMA. The research was previously presented as a late-breaking study at ACC.23. 

Displaying 25 - 32 of 109

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

 

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup